✣OncoGonFROM DISCOVERY TO IMPACT
HomeAssetsTriage & Prioritisation
3D Tumour IntelligenceExperimentsImagingSegmentation & QCResponse AnalysisAI Analysis (OSIEL)
Qualified AssetsIndustry & Data RoomCollaborationReports & Insights
Admin
Home3D Tumour IntelligenceBC-002
Loading study workspace…
3D Tumour Intelligence

BC-002

TreatmentSIMULATED MODE

Dose Response Validation

AssetOGC-BC-118CancerBreast CancerSubtypeHR+ / HER2+Model3D Tumour SpheroidLead ScientistDr. J. Patel
Review DiscussionAsk OSIEL About This Study

Study Summary

Scientific context and protocol

Dose escalation may clarify the selective response window.

Linked AssetOGC-BC-118
Cancer / SubtypeBreast Cancer · HR+ / HER2+
Model3D Tumour Spheroid
InvestigatorsDr. Sarah Mokoena · Dr. J. Patel
ProtocolOG-PROT-3D-025
Start Date2026-09-25
Current StageTreatment
Data ModeSIMULATED

Key Result

Day 7 response · illustrative scientific data

HIGH DOSE

Analysis Pending

Study has not reached final response analysis.

ViabilityPending
Tumour sizePending
ConfidencePending

Treatment Overview

Control and two intervention groups

Control0 · 3 replicates
Low Dose0.1 µM · 3 replicates
High Dose0.8 µM · 3 replicates

Timepoints

Longitudinal image and response capture

Day 0Day 3Day 7

Current analytical timepoint: Not yet analysed.

Study Timeline

Completed, current, and upcoming workflow

Setup
Samples
Treatment
Imaging
Segmentation & QC
Response Analysis
Scientific Review
Approved Result

Current Alerts

Research review required

Treatment review pendingNeeds Review
Pending QC status requires confirmationNeeds Review

Study Context

Current scientific record

StageTreatment
QCPending
ProtocolOG-PROT-3D-025
Images64
Last Updated2026-10-02

Current Attention

Research review queue

Treatment review pendingPending QC status requires confirmation
Research data · human review required.